Roche immunoassay B-type natriuretic peptide precursor assay second generation
Taiwan·Risk Class 2·ROCHE DIAGNOSTICS GMBH·Registered Dec 29, 2022 – Dec 29, 2027Active- Analysis ID
- 22165506de2ee178ed749b298fc609c9
- Customs Code
- DHA05603589309
- Manufacturer
- ROCHE DIAGNOSTICS GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- ROCHE DIAGNOSTICS LTD.
- Intended Use
- This product uses electrochemiluminescence immunoassay (ECLIA) and cobas e immunoassay to quantitatively detect N-terminal pro B-type natriuretic peptide (NT-proBNP) in human serum and plasma in vitro.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1150 校正品;; A.1117 B型利尿鈉肽試驗系統
- Import Information
- Input;; QMS/QSD
- Registration Date
- Dec 29, 2022
- Expiry Date
- Dec 29, 2027
Top companies providing products similar to "Roche immunoassay B-type natriuretic peptide precursor assay second generation"
Recently registered similar products
Access comprehensive regulatory information for Roche immunoassay B-type natriuretic peptide precursor assay second generation in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 22165506de2ee178ed749b298fc609c9 and manufactured by ROCHE DIAGNOSTICS GMBH. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including ROCHE DIAGNOSTICS GMBH, and 2 recent registrations in the same category. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.